Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Age at onset (AAO) is an essential feature of Parkinson's disease (PD) and can help predict disease progression and mortality. Identification of genetic variants influencing AAO of PD could lead to a better understanding of the disease's biological mechanism and provide clinical guidance. However, genetic determinants for AAO of PD remain mostly unknown, especially in the Asian population.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objectives</h3><p>To identify genetic determinants for AAO of PD in the Asian population.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>We performed a genome‐wide association meta‐analysis on AAO of PD in 5166 Chinese patients with PD (N<sub>discovery</sub> = 3628, N<sub>replication</sub> = 1538). We then conducted a further cross‐ethnic meta‐analysis using our results and summary statistics for the AAO of PD from the European population. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The total heritability of AAO of PD was around 0.10 ~ 0.14, similar to that (~0.11) estimated in populations of European ancestry. One novel significant intergenic locus rs9783733 (<i>NDN</i>; <i>PWRN4</i>) was identified (<i>P</i> = 3.14E‐09, beta = 2.30, SE = 0.39). Remarkably, this variant could delay AAO of PD by ~2.43 years, with a more considerable effect on males (~3.18 years) than females (~1.45 years). The variant was suggestively significant in the cross‐ethnic meta‐analysis and suggested a positive selection in the East Asian population. Additionally, cross‐ethnic meta‐analysis identified a significant locus rs356203 in <i>SNCA</i> (<i>P</i> = 2.35E‐11, beta = −0.71, SE = 0.01). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>These findings improve the current understanding of the genetic etiology of AAO of PD in different ethnic groups, and provide a new target for further research on PD pathogenesis and potential therapeutic options. © 2021 International Parkinson and Movement Disorder Society</p></section>

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort

A modifier of Huntington's disease onset at the MLH1 locus

(CAG)n loci as genetic modifiers of age-at-onset in patients with Machado-Joseph disease from mainland China.

Huntingtin-associated Protein-1 is a Modifier of the Age-at-onset of Huntington's Disease.

Association of Mitochondrial DNA Polymerase Γ Gene POLG1 Polymorphisms with Parkinsonism in Chinese Populations.

Genetic modifiers of somatic expansion and clinical phenotypes in Huntington's disease reveal shared and tissue-specific effects

Combined epigenetic/genetic study identified an ALS age of onset modifier.

Ccg Polymorphisms in the Huntingtin Gene Have No Effect on the Pathogenesis of Patients with Huntington'S Disease in Mainland Chinese Families

Expression of the Gene Coading for PGC-1α in Peripheral Blood Leukocytes and Related Gene Variants in Patients with Parkinson's Disease

SNCAGene, but NotMAPT, Influences Onset Age of Parkinson’s Disease in Chinese and Australians

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis

The potential benefits of PGC-1α in treating Alzheimer's disease are dependent on the integrity of the LLKYL L3 motif: Effect of regulating mitochondrial axonal transportation

Modifiable factors associated with Huntington's disease progression in presymptomatic participants

Genetic Modifiers of Age at Onset for Parkinson's Disease in Asians: A Genome‐Wide Association Study

Hypermethylation of the Gene Coding for PGC-1α in Peripheral Blood Leukocytes of Patients with Parkinson’s Disease

Polymorphic rs9471643 and rs6458238 upregulate PGC transcription and protein expression in overdominant or dominant models.

Deciphering the role of PGC-1α in neurological disorders: from mitochondrial dysfunction to synaptic failure

GCH1 Variants Contribute to the Risk and Earlier Age-at-onset of Parkinson’s Disease: a Two-Cohort Case-Control Study

Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice

Variants in the SNCA Gene Associate with Motor Progression While Variants in the MAPT Gene Associate with the Severity of Parkinson's Disease.

Alzheimer's disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner